We Should Do More to Offer Evidence-Based Treatment for an Important Modifiable Risk Factor for COVID-19: Obesity

Research output: Contribution to journalComment/debatepeer-review

Abstract

Observational studies, from multiple countries, repeatedly demonstrate an association between obesity and severe COVID-19, which is defined as need for hospitalization, intensive care unit admission, invasive mechanical ventilation (IMV) or death. Meta-analysis of studies from China, USA, and France show odds ratio (OR) of 2.31 (95% CI 1.3-4.1) for obesity and severe COVID-19. Other studies show OR of 12.1 (95% CI 3.25-45.1) for mortality and OR of 7.36 (95% CI 1.63-33.14) for need for IMV for patients with body mass index (BMI) ≥ 35 kg/m2. Obesity is the only modifiable risk factor that is not routinely treated but treatment can lead to improvement in visceral adiposity, insulin sensitivity, and mortality risk. Increasing the awareness of the association between obesity and COVID-19 risk in the general population and medical community may serve as the impetus to make obesity identification and management a higher priority.

Original languageEnglish (US)
JournalJournal of Primary Care and Community Health
Volume12
DOIs
StatePublished - Mar 3 2021

Bibliographical note

Publisher Copyright:
© The Author(s) 2021.

Keywords

  • BMI
  • COVID-19
  • SARS-CoV-2
  • obesity
  • weight

PubMed: MeSH publication types

  • Journal Article

Fingerprint

Dive into the research topics of 'We Should Do More to Offer Evidence-Based Treatment for an Important Modifiable Risk Factor for COVID-19: Obesity'. Together they form a unique fingerprint.

Cite this